LARGO, Fla. - eTradeWire -- Residents of St. Petersburg, Largo, and the greater Tampa Bay Area now have access to even more opportunities to receive the latest in medical care, thanks to a new location for a leading clinical research site.

Accel Research Sites Network recently opened its St. Petersburg-Largo Clinical Research Unit at 8250 Bryan Dairy Road, Suite 200, in Largo. The site combines the network's former St. Petersburg and Tampa units into an improved and expanded facility, offering patients a powerhouse of resources for vaccine, central nervous system, psychiatric, and internal medicine trials and advancements.

In addition, the new facility offers important phase I capabilities with four state-of-the-art patient rooms that will allow for overnight observation.

"Tampa and St. Petersburg have always been important communities for us to serve," said Lora Parahovnik, Accel Research Sites Network CEO. "We're thrilled to be able to bring together all of our resources in the region to better serve patients here with clinical trials that will move medicine forward."

More on eTradeWire News

• Billboard, Music Week, and DJ Times Charting Recording Artist, NOAH, Releases Groundbreaking Single "BABYMAKER"
• Empowering Small and Medium-Sized Businesses with Essential Cybersecurity in Richmond, VA
• Zamip Patel, M.D. honored with "Champion of Impact" Award
• International Speaker Christina Aldan Co-facilitates Emotional Resilience Webinar
• A Riveting New Film Project "Fade In, Fade Out" Launches on Indiegogo

The suite was custom designed within the existing building to meet the unique clinical needs of Accel and to fit the long-term vision for the site. It features 8,460 square feet of space. In addition to the four inpatient beds, the unit includes an on-site lab, eight exam rooms, a full capability infusion suite, two monitor rooms and more. It brings together three of Accel's primary investigators: Dr. Hiten Upadhyay, Dr. Deborah A. Burke and Dr. Rosario B. Hidalgo, who are top enrollers for clinical trials for migraine, depression, ADHD, hypertension, vaccines and more.

With their years of experience, the clinic is well-suited to run trials for 28 different indications. Accel will also be adding four local jobs with the move, focusing on support staff.

The new location is now open and accepting patients.

For more information about Accel Research Sites Network or to sign up for a clinical trial, visit https://accelresearchsites.com/.

More on eTradeWire News

• Are Courageous Women in Stories More Intriguing?
• "Dear Dyslexia – Thank You for All You Have Done" Launches Today in Paperback and on Kindle
• Start Your Own Business and Improve Your Credit
• Multi-Talented Reggae Artist, Songwriter and Producer "GERNADO" Releases New Single - Come To ME
• Evelyn Magley Name One Of Hope Magazine's 2023 Hope 25

For images of the new location, click here (https://www.dropbox.com/sh/xif83zpqbhj9c51/AAD0IxlQpG0vB34eBNxQTcnRa?dl=0).

About Accel Research Sites Network

Accel Research Sites Network is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

Media Contact

Will Wellons

Wellons Communications

407-462-2718

will@wellonscommunications.com